摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

8-amino-6H-benzo[c]chromen-6-one | 27421-12-1

中文名称
——
中文别名
——
英文名称
8-amino-6H-benzo[c]chromen-6-one
英文别名
8-amino-benzo[c]chromen-6-one;8-Aminobenzo[c]chromen-6-one
8-amino-6H-benzo[c]chromen-6-one化学式
CAS
27421-12-1
化学式
C13H9NO2
mdl
——
分子量
211.22
InChiKey
JAONNXSTACOXOT-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.4
  • 重原子数:
    16
  • 可旋转键数:
    0
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    52.3
  • 氢给体数:
    1
  • 氢受体数:
    3

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    8-amino-6H-benzo[c]chromen-6-one二异丁基氢化铝 作用下, 以 甲苯 为溶剂, 反应 18.0h, 生成 2,2,4-Trimethyl-1,5-dihydrochromeno[3,4-f]quinolin-5-ol
    参考文献:
    名称:
    Development of progesterone receptor antagonists from 1,2-dihydrochromeno[3,4-f]quinoline agonist pharmacophore
    摘要:
    A series of 1,2-dihydrochromeno[3,4-f]quinoline derivatives was synthesized and tested in biological assays to evaluate the nonsteroidal progesterone receptor modulator pharmacophore (4) as antiprogestins. A number of potent analogues were identified by modification of the substituents at the D-ring. (C) 2003 Elsevier Science Ltd. All rights reserved.
    DOI:
    10.1016/s0960-894x(03)00256-7
  • 作为产物:
    描述:
    8-nitro-6H-benzo[c]chromen-6-one 在 palladium on activated charcoal 氢气 作用下, 以 乙酸乙酯 为溶剂, 反应 24.0h, 以86%的产率得到8-amino-6H-benzo[c]chromen-6-one
    参考文献:
    名称:
    5-芳基-1,2-二氢色素[3,4-f]喹啉:一类新的非甾体类人孕激素受体激动剂。
    摘要:
    描述了新型非甾体类人孕激素受体(hPR)激动剂5-芳基-1,2-二氢-5H-chromeno [3,4-f]喹啉2的开发。将5-芳基基团引入1,2-二氢香豆素[3,4-f]喹啉核心1是促孕活动的关键。对5-芳基取代基的结构活性关系(SAR)研究产生了一系列有效的hPR激动剂,它们在细胞内显示出与天然激素孕酮(EC50 = 2.9 nM)类似的生物学活性(EC50 = 8-30 nM)。效率范围从28%到96%的检测。大多数类似物表现出与孕酮(Ki = 3.5 nM)相似或更高的结合亲和力(Ki = 0.41-3.6 nM)。三个代表性的类似物(13、15和24)在去卵巢大鼠的乳腺形态/子宫湿重测定中显示了体内活性。
    DOI:
    10.1021/jm9705768
点击查看最新优质反应信息

文献信息

  • NOVEL 1,2-DIHYDROQUINOLINE DERIVATIVE HAVING (SUBSTITUTED PHENYL OR SUBSTITUTED HETEROCYCLIC) CARBONYLOXY LOWER ALKYL GROUP AND ESTER-INTRODUCED PHENYL GROUP AS SUBSTITUENTS
    申请人:Matsuda Mamoru
    公开号:US20090298826A1
    公开(公告)日:2009-12-03
    The compounds represented in general formula (1) and a salt thereof are useful for glucocorticoid receptor modulator. The R 1 represents a hydrogen atom or a lower alkyl group; R 2 represents a hydrogen atom or a lower alkyl group; R 3 and R 4 may be the same or different and represent a hydrogen atom or a lower alkyl group; R 5 represents a hydrogen atom or a lower alkyl group; R 6 represents a halogen atom, a lower alkyl group, a hydroxy group, a lower alkoxy group, a nitro group or a cyano group; X represents —C(O)—, —C(O)NR 8 —, —S(O) 2 — and the like; R 7 and/or R 8 may be the same or different and represent a hydrogen atom, a lower alkyl group which may have a substituent, an aryl group which may have a substituent, a heterocyclic group which may have a substituent, a lower alkoxy group which may have a substituent and the like; Y represents a lower alkylene group; Z represents a benzene ring or a heterocyclic ring; and P represents 0, 1, 2 or 3.
    通用公式(1)中代表的化合物及其盐对糖皮质激素受体调节剂非常有用。其中,R1代表氢原子或较低的烷基基团;R2代表氢原子或较低的烷基基团;R3和R4可以相同也可以不同,代表氢原子或较低的烷基基团;R5代表氢原子或较低的烷基基团;R6代表卤素原子、较低的烷基基团、羟基、较低的烷氧基、硝基或氰基;X代表—C(O)—、—C(O)NR8—、—S(O)2—等;R7和/或R8可以相同也可以不同,代表氢原子、可能具有取代基团的较低烷基基团、可能具有取代基团的芳基、可能具有取代基团的杂环基团、可能具有取代基团的较低烷氧基团等;Y代表较低的烷基烯基团;Z代表苯环或杂环环;P代表0、1、2或3。
  • Ruthenium-Catalyzed C–H Arylation of Diverse Aryl Carboxylic Acids with Aryl and Heteroaryl Halides
    作者:Liangbin Huang、Daniel J. Weix
    DOI:10.1021/acs.orglett.6b02862
    日期:2016.10.21
    ligated to tricyclohexylphosphine or di-tert-butylbipyridine catalyzes the arylation of carboxylic acids with diverse aryl halides (iodide, bromide, and triflate; aryl and heteroaryl). In addition, arylations with 2-iodophenol formed benzochromenones, carboxylate was shown to be a stronger donor than an amide, and the arylation of a pyridine carboxylate was demonstrated. Stoichiometric studies demonstrated
    与三环己基膦或二叔丁基联吡啶连接的钌催化羧酸与各种芳基卤化物(碘化物,溴化物和三氟甲磺酸盐;芳基和杂芳基)的芳基化反应。此外,与2-碘苯酚的芳基化反应形成苯并铬酮,表明羧酸盐是比酰胺更强的供体,并且证明了吡啶羧酸盐的芳基化。化学计量学研究表明,添加的配体是与亲电子试剂反应所必需的,而不是C–H键。
  • 5-Aryl-1,2-dihydrochromeno[3,4-<i>f</i>]quinolines:  A Novel Class of Nonsteroidal Human Progesterone Receptor Agonists
    作者:Lin Zhi、Christopher M. Tegley、E. Adam Kallel、Keith B. Marschke、Dale E. Mais、Marco M. Gottardis、Todd K. Jones
    DOI:10.1021/jm9705768
    日期:1998.1.1
    The development of a novel class of nonsteroidal human progesterone receptor (hPR) agonists, 5-aryl-1,2-dihydro-5H-chromeno[3,4-f]quinolines 2, is described. The introduction of a 5-aryl group into the 1,2-dihydrocoumarino[3,4-f]quinoline core 1 is the key for progestational activities. The structure-activity relationship (SAR) studies of the 5-aryl substituents generated a series of potent hPR agonists
    描述了新型非甾体类人孕激素受体(hPR)激动剂5-芳基-1,2-二氢-5H-chromeno [3,4-f]喹啉2的开发。将5-芳基基团引入1,2-二氢香豆素[3,4-f]喹啉核心1是促孕活动的关键。对5-芳基取代基的结构活性关系(SAR)研究产生了一系列有效的hPR激动剂,它们在细胞内显示出与天然激素孕酮(EC50 = 2.9 nM)类似的生物学活性(EC50 = 8-30 nM)。效率范围从28%到96%的检测。大多数类似物表现出与孕酮(Ki = 3.5 nM)相似或更高的结合亲和力(Ki = 0.41-3.6 nM)。三个代表性的类似物(13、15和24)在去卵巢大鼠的乳腺形态/子宫湿重测定中显示了体内活性。
  • Novel 1-2-Dihydroquinoline Derivative Having Glucocorticoid Receptor Binding Activity
    申请人:Matsuda Mamoru
    公开号:US20090326009A1
    公开(公告)日:2009-12-31
    An object of the present invention is to study synthesis of a novel 1,2-dihydroquinoline derivative and to find a pharmacological action of the derivative. A compound represented by the general formula (1) or a salt thereof is effective in the treatment of a glucocorticoid receptor-related disease. In the formula, the ring X represents a benzene ring or a pyridine ring; R 1 represents a halogen atom, an alkyl group, a hydroxy group, an alkoxy group, an amino group or the like; p represents an integer of 0 to 5; R 2 represents a halogen atom, an alkyl group, a hydroxy group or the like; q represents an integer of 0 to 2; R 3 represents a hydrogen atom, an alkyl group, an alkenyl group or the like; R 4 and R 5 represent a hydrogen atom or the like; R 6 represents a hydrogen atom or the like; A represents an alkylene group or the like; and R 7 represents OR 8 , NR 8 R 9 , SR 8 , S(O)R 8 or S(O) 2 R 8 , wherein R 8 represents an aryl group, a heterocyclic group or the like and R 9 represents a hydrogen atom or the like.
    本发明的目的是研究合成一种新型1,2-二氢喹啉衍生物,并发现该衍生物的药理作用。通式(1)表示的化合物或其盐在治疗糖皮质激素受体相关疾病方面具有有效性。在该式中,环X表示苯环或吡啶环;R1表示卤素原子、烷基、羟基、烷氧基、氨基或类似物;p表示0至5的整数;R2表示卤素原子、烷基、羟基或类似物;q表示0至2的整数;R3表示氢原子、烷基、烯基或类似物;R4和R5表示氢原子或类似物;R6表示氢原子或类似物;A表示烷基链或类似物;R7表示OR8、NR8R9、SR8、S(O)R8或S(O)2R8,其中R8表示芳基、杂环基或类似物,R9表示氢原子或类似物。
  • NOVEL 1,2-DIHYDROQUINOLINE DERIVATIVE HAVING SUBSTITUTED PHENYLAMINO LOWER ALKYL GROUP AND ESTER-INTRODUCED PHENYL GROUP AS SUBSTITUENTS
    申请人:Matsuda Mamoru
    公开号:US20090298827A1
    公开(公告)日:2009-12-03
    The compounds represented in general formula (1) and a salt thereof are useful for glucocorticoid receptor modulator. The R 1 represents a hydrogen atom or a lower alkyl group; R 2 represents a hydrogen atom or a lower alkyl group; R 3 and R 4 may be the same or different and represents a hydrogen atom or a lower alkyl group; R 5 represents a hydrogen atom or a lower alkyl group; R 6 represents a halogen atom, a lower alkyl group, a hydroxy group, a lower alkoxy group, a nitro group or a cyano group; X represents —C(O)—, —C(O)NR 8 —, —S(O) 2 — and the like; R 7 and/or R 8 may be the same or different and represent a hydrogen atom, a lower alkyl group which may have a substituent, an aryl group which may have a substituent, a heterocyclic group which may have a substituent, a lower alkoxy group which may have a substituent and the like; Y represents a lower alkylene group; and P represents 0, 1, 2 or 3.
    通式(1)及其盐对于糖皮质激素受体调节剂很有用。其中,R1代表氢原子或较低烷基;R2代表氢原子或较低烷基;R3和R4可以相同也可以不同,代表氢原子或较低烷基;R5代表氢原子或较低烷基;R6代表卤原子、较低烷基、羟基、较低烷氧基、硝基或氰基;X代表—C(O)—,—C(O)NR8—,—S(O)2—等;R7和/或R8可以相同也可以不同,代表氢原子、较低烷基(可能具有取代基)、芳基(可能具有取代基)、杂环基(可能具有取代基)、较低烷氧基(可能具有取代基)等;Y代表较低烷基烯基;P代表0、1、2或3。
查看更多